Mortality Rate Improvements – End of an Era, For Now…
Improvements in mortality rates characterized the twentieth century – the trend of living ever longer and healthier lives seemed assured. Recent mortality rates, however, point to a change. The positive trend has slowed. But why? Are all ages affected? And surely medical advances will anyway have us back on track asap?
Look Beyond the Medical Treatments (SCORviews)
If mortality improvement is a three-legged stool, improved treatment of disease is only one leg; the other two legs are prevention and early detection
Stroke in Younger Adults - Have Improvements Reached Their Limit?
Age remains the most consistent risk factor for ischaemic stroke. Surprisingly then an estimated 10% of diagnoses are now seen in people below the age of 50.
Genetic Testing – What Does the Crystal Ball Really Reveal?
Knowing the basics of genetic testing and its underlying science is the first step in understanding genetic testing’s potential impact on insurance. Genetic testing is best defined as the analysis of DNA, RNA, chromosomes, proteins and metabolites in relation to heritable risks, traits, and conditions.
Impaired Lives May Be Hot: RGA
The world's biggest life and health insurers may be putting more energy into developing new underwriting strategies for older, sicker people than for younger, healthier people.
Progress in the Management of Multiple Sclerosis
Multiple Sclerosis (MS) presents a challenge to insurers due to its complex, unpredictable course.
SCORviews October 2017 Issue
Articles featured in the October 2017 issue of SCORviews include:
- Modeling Policyholder Behavior
- Innovations in Life Insurance
- SCOR Mortality Insight
Master the Facultative Submission Puzzle
Life insurance underwriting isn’t just a job – it’s an art, a science and, at times, a puzzle. To piece together a particularly complex or challenging case, it often makes sense to seek facultative consideration from a reinsurer. Find tips and tools here to make the process easier, including a sample cover letter.
Breast Cancer in Women (SCOR inFORM)
Breast cancer in women is a real public health issue. All doctors, whatever their specialty, are confronted to some extent with patients with this type of tumor. It is the second most common type of cancer in the world. Breast cancer is responsible for more than 520,000 deaths each year, and is the fifth most frequent cause of death in the world.
How 3D Printing Is Changing Medical Treatment
It’s not so surprising that solid objects made from printed plastic or titanium, such as replacement hip joints or dental implants, can be made by 3D printers. More remarkable is that new human tissue might be printed from bio-ink comprising of droplets of living cells, stem cells and other biomaterials to replace or support an existing biological structure - a process known as regenerative medicine.